Discrepancy between direct and antibody-dependent cytotoxic activities of human LAK cells

Area of Science:

• Immunology
• Cell Biology
• Cancer Research

Background:

• Human lymphokine-activated killer (LAK) cells are crucial for targeting natural killer (NK)-resistant tumor cells.
• LAK cells exhibit both antibody-independent and antibody-dependent cytotoxic mechanisms.
• Understanding the modulation of LAK cell activity during generation is vital for immunotherapy.

Purpose of the Study:

• To compare antibody-independent LAK activity and antibody-dependent cellular cytotoxicity (ADCC) in LAK cells generated with interleukin-2 (IL-2).
• To investigate the phenotypical changes in LAK cells during IL-2 stimulation.
• To elucidate the distinct effector pathways and their relation to cell surface molecule expression.

Main Methods:

• Culturing human lymphocytes with IL-2 for 3 or 7 days to generate LAK cells.
• Assessing LAK activity against untreated Raji cells.
• Measuring ADCC against antibody-coated Raji cells.
• Performing phenotypical analysis using flow cytometry to identify cell surface markers like CD11b and CD16.

Main Results:

• IL-2 stimulation significantly increased LAK activity after 3 or 7 days compared to non-activated cells.
• ADCC was reduced in 3-day LAK cells but augmented in 7-day LAK cells.
• IL-2 induced upregulation of CD11b+ lymphocytes in 7-day LAK cells, while CD16+ cells remained unchanged.

Conclusions:

• Human LAK cells possess distinct antibody-dependent and -independent cytotoxic activities mediated by different effector pathways.
• The stage of LAK cell generation influences both cytotoxic potential and phenotypical characteristics.
• Changes in adhesion molecule expression, particularly CD11b/CD18, are associated with IL-2-activated lymphocyte function during LAK cell generation.